1. Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways
   Xiangning Bu et al, 2018, Biochemical Pharmacology CrossRef
2. Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer
   Wenli Yuan et al, 2018, Cancer Immunol Immunother CrossRef
3. Effects of β-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions
   Li Zhou et al, 2018, Int J Oncol CrossRef
4. FOS licenses early events in stem cell activation driving skeletal muscle regeneration
   Albert E. Almada et al, 2021, Cell Reports CrossRef
5. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight
   Ann-Katrin Hopp et al, 2021, Cells CrossRef
6. Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis
   Shuxian Zhang et al, 2021, Med Oncol CrossRef
7. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non–small cell lung cancer
   Erik Wennerberg et al, 2022, Sci. Transl. Med. CrossRef
8. Arginine ADP-ribosyltransferase 1 Regulates Glycolysis in Colorectal Cancer via the PI3K/AKT/HIF1α Pathway
   Wen-bo Long et al, 2022, CURR MED SCI CrossRef
9. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning
   Amin Aliabadi et al, 2023, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
10. ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells
    Ting Lin et al, 2024, BMC Cancer CrossRef
11. Promising anticancer activity of cromolyn in colon cancer: in vitro and in vivo analysis
    Amin Aliabadi et al, 2024, J Cancer Res Clin Oncol CrossRef